The HIF-1α stimulation under inflammation-associated hypoxic conditions promotes CD4+ T cells to convert to regulatory T (Treg) cells, which produce the anti-inflammatory cytokine interleukin (IL)-10, and this plays an important role in protection against IBD [51]. Here, HIF1A is linked to inflammatory bowel disease.